CHEMED CORP (CHE) Fundamental Analysis & Valuation

NYSE:CHE • US16359R1032

Current stock price

386.36 USD
+5.76 (+1.51%)
At close:
386.36 USD
0 (0%)
After Hours:

This CHE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. CHE Profitability Analysis

1.1 Basic Checks

  • In the past year CHE was profitable.
  • In the past year CHE had a positive cash flow from operations.
  • CHE had positive earnings in each of the past 5 years.
  • In the past 5 years CHE always reported a positive cash flow from operatings.
CHE Yearly Net Income VS EBIT VS OCF VS FCFCHE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • CHE has a better Return On Assets (17.24%) than 100.00% of its industry peers.
  • With an excellent Return On Equity value of 27.08%, CHE belongs to the best of the industry, outperforming 93.00% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 21.08%, CHE belongs to the top of the industry, outperforming 94.00% of the companies in the same industry.
  • CHE had an Average Return On Invested Capital over the past 3 years of 21.04%. This is significantly above the industry average of 8.63%.
  • The last Return On Invested Capital (21.08%) for CHE is above the 3 year average (21.04%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 17.24%
ROE 27.08%
ROIC 21.08%
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
CHE Yearly ROA, ROE, ROICCHE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

1.3 Margins

  • CHE has a better Profit Margin (10.48%) than 97.00% of its industry peers.
  • In the last couple of years the Profit Margin of CHE has declined.
  • Looking at the Operating Margin, with a value of 14.01%, CHE belongs to the top of the industry, outperforming 86.00% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CHE has declined.
  • CHE has a Gross Margin of 32.54%. This is in the better half of the industry: CHE outperforms 65.00% of its industry peers.
  • In the last couple of years the Gross Margin of CHE has remained more or less at the same level.
Industry RankSector Rank
OM 14.01%
PM (TTM) 10.48%
GM 32.54%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
CHE Yearly Profit, Operating, Gross MarginsCHE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

8

2. CHE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CHE is creating value.
  • Compared to 1 year ago, CHE has less shares outstanding
  • CHE has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CHE has a worse debt to assets ratio.
CHE Yearly Shares OutstandingCHE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
CHE Yearly Total Debt VS Total AssetsCHE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.2 Solvency

  • CHE has an Altman-Z score of 10.82. This indicates that CHE is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 10.82, CHE belongs to the top of the industry, outperforming 95.00% of the companies in the same industry.
  • CHE has a debt to FCF ratio of 0.03. This is a very positive value and a sign of high solvency as it would only need 0.03 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.03, CHE belongs to the top of the industry, outperforming 92.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.01 indicates that CHE is not too dependend on debt financing.
  • CHE has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. CHE outperforms 84.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.03
Altman-Z 10.82
ROIC/WACC2.34
WACC9%
CHE Yearly LT Debt VS Equity VS FCFCHE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.3 Liquidity

  • CHE has a Current Ratio of 1.05. This is a normal value and indicates that CHE is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.05, CHE is not doing good in the industry: 66.00% of the companies in the same industry are doing better.
  • A Quick Ratio of 1.03 indicates that CHE should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.03, CHE is doing worse than 63.00% of the companies in the same industry.
  • The current and quick ratio evaluation for CHE is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.03
CHE Yearly Current Assets VS Current LiabilitesCHE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

4

3. CHE Growth Analysis

3.1 Past

  • CHE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.70%.
  • The Earnings Per Share has been growing slightly by 3.61% on average over the past years.
  • Looking at the last year, CHE shows a small growth in Revenue. The Revenue has grown by 4.06% in the last year.
  • The Revenue has been growing slightly by 4.00% on average over the past years.
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.57% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 5.67% on average over the next years.
EPS Next Y12.32%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue Next Year4.7%
Revenue Next 2Y5.46%
Revenue Next 3Y5.67%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CHE Yearly Revenue VS EstimatesCHE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
CHE Yearly EPS VS EstimatesCHE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5 10 15 20 25

5

4. CHE Valuation Analysis

4.1 Price/Earnings Ratio

  • CHE is valuated rather expensively with a Price/Earnings ratio of 17.90.
  • Based on the Price/Earnings ratio, CHE is valued a bit cheaper than 70.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.21, CHE is valued a bit cheaper.
  • The Price/Forward Earnings ratio is 15.93, which indicates a correct valuation of CHE.
  • 71.00% of the companies in the same industry are more expensive than CHE, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of CHE to the average of the S&P500 Index (23.13), we can say CHE is valued slightly cheaper.
Industry RankSector Rank
PE 17.9
Fwd PE 15.93
CHE Price Earnings VS Forward Price EarningsCHE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHE indicates a somewhat cheap valuation: CHE is cheaper than 63.00% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, CHE is valued a bit cheaper than the industry average as 70.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.35
EV/EBITDA 12.51
CHE Per share dataCHE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • CHE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of CHE may justify a higher PE ratio.
PEG (NY)1.45
PEG (5Y)4.95
EPS Next 2Y12.04%
EPS Next 3Y10.57%

6

5. CHE Dividend Analysis

5.1 Amount

  • CHE has a yearly dividend return of 0.65%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.50, CHE pays a better dividend. On top of this CHE pays more dividend than 81.00% of the companies listed in the same industry.
  • With a Dividend Yield of 0.65, CHE pays less dividend than the S&P500 average, which is at 1.89.
Industry RankSector Rank
Dividend Yield 0.65%

5.2 History

  • The dividend of CHE is nicely growing with an annual growth rate of 11.06%!
  • CHE has paid a dividend for at least 10 years, which is a reliable track record.
  • CHE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.06%
Div Incr Years17
Div Non Decr Years22
CHE Yearly Dividends per shareCHE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 11.95% of the earnings are spent on dividend by CHE. This is a low number and sustainable payout ratio.
  • CHE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP11.95%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
CHE Yearly Income VS Free CF VS DividendCHE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M
CHE Dividend Payout.CHE Dividend Payout, showing the Payout Ratio.CHE Dividend Payout.PayoutRetained Earnings

CHE Fundamentals: All Metrics, Ratios and Statistics

CHEMED CORP

NYSE:CHE (4/6/2026, 8:26:57 PM)

After market: 386.36 0 (0%)

386.36

+5.76 (+1.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)04-23
Inst Owners101.6%
Inst Owner Change0%
Ins Owners1.54%
Ins Owner Change-1.34%
Market Cap5.32B
Revenue(TTM)2.53B
Net Income(TTM)265.24M
Analysts75
Price Target451.86 (16.95%)
Short Float %3.2%
Short Ratio1.76
Dividend
Industry RankSector Rank
Dividend Yield 0.65%
Yearly Dividend2.24
Dividend Growth(5Y)11.06%
DP11.95%
Div Incr Years17
Div Non Decr Years22
Ex-Date02-23
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.47%
Min EPS beat(2)-10.06%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-6.89%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)1
Avg EPS beat(8)-5.02%
EPS beat(12)3
Avg EPS beat(12)-3.1%
EPS beat(16)7
Avg EPS beat(16)-1.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.96%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.96%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)2
Avg Revenue beat(16)-1.4%
PT rev (1m)-20.25%
PT rev (3m)-22.86%
EPS NQ rev (1m)-3.9%
EPS NQ rev (3m)-11.53%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.76%
Revenue NQ rev (1m)-0.33%
Revenue NQ rev (3m)-2.46%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-1.43%
Valuation
Industry RankSector Rank
PE 17.9
Fwd PE 15.93
P/S 2.1
P/FCF 16.35
P/OCF 13.7
P/B 5.43
P/tB 23.17
EV/EBITDA 12.51
EPS(TTM)21.59
EY5.59%
EPS(NY)24.25
Fwd EY6.28%
FCF(TTM)23.64
FCFY6.12%
OCF(TTM)28.2
OCFY7.3%
SpS183.73
BVpS71.13
TBVpS16.68
PEG (NY)1.45
PEG (5Y)4.95
Graham Number185.88
Profitability
Industry RankSector Rank
ROA 17.24%
ROE 27.08%
ROCE 28.33%
ROIC 21.08%
ROICexc 22.41%
ROICexgc 60.78%
OM 14.01%
PM (TTM) 10.48%
GM 32.54%
FCFM 12.86%
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
ROICexc(3y)24.14%
ROICexc(5y)24.65%
ROICexgc(3y)64.18%
ROICexgc(5y)68.12%
ROCE(3y)28.21%
ROCE(5y)29.9%
ROICexgc growth 3Y-2.67%
ROICexgc growth 5Y-7.4%
ROICexc growth 3Y-2.26%
ROICexc growth 5Y-2.45%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
F-Score6
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.03
Debt/EBITDA 0.03
Cap/Depr 96.84%
Cap/Sales 2.48%
Interest Coverage 263.51
Cash Conversion 92.61%
Profit Quality 122.71%
Current Ratio 1.05
Quick Ratio 1.03
Altman-Z 10.82
F-Score6
WACC9%
ROIC/WACC2.34
Cap/Depr(3y)89.6%
Cap/Depr(5y)92.99%
Cap/Sales(3y)2.34%
Cap/Sales(5y)2.49%
Profit Quality(3y)114.97%
Profit Quality(5y)107.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
EPS Next Y12.32%
EPS Next 2Y12.04%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%
Revenue Next Year4.7%
Revenue Next 2Y5.46%
Revenue Next 3Y5.67%
Revenue Next 5YN/A
EBIT growth 1Y-12.87%
EBIT growth 3Y1.18%
EBIT growth 5Y1.52%
EBIT Next Year25.84%
EBIT Next 3Y13.68%
EBIT Next 5YN/A
FCF growth 1Y-11.55%
FCF growth 3Y8.82%
FCF growth 5Y-5.44%
OCF growth 1Y-7%
OCF growth 3Y7.8%
OCF growth 5Y-4.52%

CHEMED CORP / CHE Fundamental Analysis FAQ

What is the fundamental rating for CHE stock?

ChartMill assigns a fundamental rating of 7 / 10 to CHE.


What is the valuation status of CHEMED CORP (CHE) stock?

ChartMill assigns a valuation rating of 5 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.


What is the profitability of CHE stock?

CHEMED CORP (CHE) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for CHE stock?

The Price/Earnings (PE) ratio for CHEMED CORP (CHE) is 17.9 and the Price/Book (PB) ratio is 5.43.


What is the financial health of CHEMED CORP (CHE) stock?

The financial health rating of CHEMED CORP (CHE) is 8 / 10.